Lyka Labs Limited , a company listed on both BSE and NSE, has reported a significant change in its promoter shareholding. Kunal Gandhi, a promoter of the company, has increased his stake through a substantial share acquisition.

Key Details of the Transaction

Impact on Shareholding

Additional Information

• The total promoter group holding, including persons acting in concert, remains unchanged at 17.22%.
• Persons acting in concert include Nehal N. Gandhi, Enai Trading and Investment Private Limited, and Lyka Generics Limited.
• Lyka Labs' total equity share capital stands at 3,30,90,000 shares.

This transaction represents a significant increase in Kunal Gandhi's individual stake in Lyka Labs, more than doubling his shareholding percentage. However, it's important to note that the overall promoter group holding has not changed as a result of this internal transfer of shares.

Lyka Labs has reported an update on its ongoing Scheme of Amalgamation proceedings at the National Company Law Tribunal (NCLT), Ahmedabad Bench. The NCLT has extended the deadline for the Income Tax Department to submit their reply, granting an additional 15 days beyond the initially allocated 7-day period.

Extension Details

The extension was requested by the lead counsel for the Income Tax Department, citing a recent change in legal representation. The new counsel, who has replaced Ms. Maithili Mehta, required additional time to receive instructions from the department and prepare their response.

Key Dates

Background

This development follows Lyka Labs' earlier intimation dated September 18, 2025, which informed stakeholders that the NCLT had initially directed the Income Tax Department to submit its report within seven days.

Company's Disclosure

Lyka Labs has promptly disclosed this information to the stock exchanges, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also made the NCLT order available on its website ( www.lykalabs.com ) for public access.

Impact and Outlook

While the extension delays the proceedings, it ensures that all parties have adequate time to prepare their submissions. Shareholders and potential investors should note that this is a procedural development in the ongoing amalgamation process, and its full implications will become clearer as the case progresses.

Investors are advised to keep track of further updates from the company regarding the amalgamation proceedings and their potential impact on Lyka Labs' corporate structure and operations.